ACCELERON PHARMA INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 63 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-12-22: Reporting owner Kumar Ravindra; Form 4; Security Option to Purchase Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-12-22: Reporting owner Kumar Ravindra; Form 4; Security Option to Purchase Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-12-01: Reporting owner Dable Habib J; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-11-09: Reporting owner Knopf John L; Form 4; Security Option to Purchase Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-12-22 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 6,761 owned after | $5.28 exercise price | 2016-12-23 | |
| 2016-12-22 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,561 0 owned after | $3.88 exercise price | 2016-12-23 | |
| 2016-12-01 | Dable Habib J Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +400,000 400,000 owned after | $35.04 exercise price | 2016-12-05 | |
| 2016-11-09 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −31,543 18,457 owned after | $5.88 exercise price | 2016-11-14 | |
| 2016-11-09 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −37,500 12,500 owned after | $5.28 exercise price | 2016-11-14 | |
| 2016-11-09 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,375 28,125 owned after | $5.28 exercise price | 2016-11-14 | |
| 2016-11-09 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,976 21,524 owned after | $5.28 exercise price | 2016-11-14 | |
| 2016-11-09 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,606 109,027 owned after | $5.08 exercise price | 2016-11-14 | |
| 2016-10-10 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,182 937 owned after | $7.12 exercise price | 2016-10-11 | |
| 2016-10-10 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,101 16,689 owned after | $24.11 exercise price | 2016-10-11 | |
| 2016-10-10 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,550 31,850 owned after | $27.97 exercise price | 2016-10-11 | |
| 2016-10-07 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −954 4,561 owned after | $3.88 exercise price | 2016-10-11 | |
| 2016-10-07 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,984 0 owned after | $5.28 exercise price | 2016-10-11 | |
| 2016-10-07 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,115 16,761 owned after | $5.28 exercise price | 2016-10-11 | |
| 2016-10-07 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,381 5,119 owned after | $7.12 exercise price | 2016-10-11 | |
| 2016-10-07 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,210 24,790 owned after | $24.11 exercise price | 2016-10-11 | |
| 2016-10-06 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,124 17,876 owned after | $5.28 exercise price | 2016-10-11 | |
| 2016-09-21 | Quisel John D Officer (SVP, Bus. Dev., GC & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −781 1,562 owned after | $7.12 exercise price | 2016-09-23 | |
| 2016-09-21 | Quisel John D Officer (SVP, Bus. Dev., GC & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,671 15,329 owned after | $24.11 exercise price | 2016-09-23 | |
| 2016-09-21 | Quisel John D Officer (SVP, Bus. Dev., GC & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,500 5,000 owned after | $3.88 exercise price | 2016-09-23 | |
| 2016-09-12 | Quisel John D Officer (SVP, Bus. Dev., GC & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,500 16,500 owned after | $3.88 exercise price | 2016-09-13 | |
| 2016-09-12 | Quisel John D Officer (SVP, Bus. Dev., GC & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,250 0 owned after | $5.28 exercise price | 2016-09-13 | |
| 2016-09-12 | Quisel John D Officer (SVP, Bus. Dev., GC & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,688 2,343 owned after | $7.12 exercise price | 2016-09-13 | |
| 2016-08-10 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,896 0 owned after | $5.28 exercise price | 2016-08-11 | |
| 2016-08-10 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,000 8,000 owned after | $7.12 exercise price | 2016-08-11 | |
| 2016-07-25 | MCCOURT Thomas A Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $32.98 exercise price | 2016-07-25 | |
| 2016-07-07 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 1,896 owned after | $5.28 exercise price | 2016-07-07 | |
| 2016-07-07 | Ertel Steven D Officer (EVP & Chief Operating Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,421 1,883 owned after | $5.28 exercise price | 2016-07-07 | |
| 2016-07-07 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 16,251 owned after | $3.88 exercise price | 2016-07-07 | |
| 2016-07-07 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −95,000 0 owned after | $1.80 exercise price | 2016-07-07 | |
| 2016-07-06 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −41,477 42,500 owned after | $5.28 exercise price | 2016-07-06 | |
| 2016-07-05 | Ertel Steven D Officer (EVP & Chief Operating Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,966 6,304 owned after | $5.28 exercise price | 2016-07-06 | |
| 2016-07-05 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,501 83,977 owned after | $5.28 exercise price | 2016-07-06 | |
| 2016-07-01 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,896 0 owned after | $5.08 exercise price | 2016-07-06 | |
| 2016-07-01 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,500 0 owned after | $3.88 exercise price | 2016-07-06 | |
| 2016-07-01 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,604 7,896 owned after | $5.28 exercise price | 2016-07-06 | |
| 2016-07-01 | Ertel Steven D Officer (EVP & Chief Operating Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,209 0 owned after | $3.88 exercise price | 2016-07-06 | |
| 2016-07-01 | Ertel Steven D Officer (EVP & Chief Operating Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,095 10,270 owned after | $5.28 exercise price | 2016-07-06 | |
| 2016-07-01 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,300 9,400 owned after | $5.28 exercise price | 2016-07-06 | |
| 2016-07-01 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −23,022 114,478 owned after | $5.28 exercise price | 2016-07-06 | |
| 2016-05-23 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −300 24,700 owned after | $5.28 exercise price | 2016-05-25 | |
| 2016-05-20 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,787 114,633 owned after | $5.08 exercise price | 2016-05-20 | |
| 2016-05-19 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −37,623 140,420 owned after | $5.08 exercise price | 2016-05-20 | |
| 2016-05-18 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,090 178,043 owned after | $5.08 exercise price | 2016-05-20 | |
| 2016-04-07 | Ertel Steven D Officer (EVP & Chief Operating Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,942 28,365 owned after | $5.28 exercise price | 2016-04-08 | |
| 2016-04-07 | Ertel Steven D Officer (EVP & Chief Operating Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,500 12,500 owned after | $7.12 exercise price | 2016-04-08 | |
| 2016-04-07 | Ertel Steven D Officer (EVP & Chief Operating Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,344 0 owned after | $5.08 exercise price | 2016-04-08 | |
| 2016-04-07 | Ertel Steven D Officer (EVP & Chief Operating Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,484 10,209 owned after | $3.88 exercise price | 2016-04-08 | |
| 2016-04-07 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 5,896 owned after | $5.08 exercise price | 2016-04-08 | |
| 2016-03-03 | Zakrzewski Joseph S Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-03-03 | POPS RICHARD F Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-03-03 | MCGUIRE TERRANCE Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-03-03 | Maniatis Tom Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-03-03 | Kearney Terrence C Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-03-03 | George Jean Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-03-03 | Nader Francois Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-03-03 | Kumar Ravindra Officer (SVP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,400 36,400 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-03-03 | Quisel John D Officer (SVP Gen. Counsel & Secretary) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,800 30,800 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-03-03 | Sherman Matthew L Officer (EVP & Chief Medical Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-03-03 | Ertel Steven D Officer (EVP & Chief Operating Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-03-03 | MCLAUGHLIN KEVIN F Officer (SVP, CFO and Treasurer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,800 30,800 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-03-03 | Knopf John L Director, Officer (CEO and President) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +105,000 105,000 owned after | $27.97 exercise price | 2016-03-07 | |
| 2016-02-25 | Kumar Ravindra Officer (VP & Chief Scientific Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,000 5,515 owned after | $3.88 exercise price | 2016-02-29 |